As CBD continues to explode in popularity, brands are beginning to take notice. Innovative companies are already beginning to offer products centered around one of the other 100+ cannabinoids found in the plant.
One of those cannabinoids is Cannabigerol, or CBG. First discovered by researchers in the 1960’s, CBG is the precursor from which all other cannabinoids are synthesized, which is why it’s often referred to as the “mother” or “stem cell” of cannabinoids. This unique property imbues CBG with enormous therapeutic promise, making it a subject of great interest for researchers and consumers alike.
Despite the medical appeal and consumer demand there’s one big hurdle to face, though: CBG is notoriously expensive to produce, so much so it’s been dubbed the “the Rolls Royce of cannabinoids.”
“It takes thousands of pounds of biomass to create small amounts of CBG isolate,” continues Rowland. “That’s because most hemp only contains minute percentages of CBG, whereas there are now hemp strains that contain 20% CBD in the crop. If the CBG content of the same crop is only 1%, that means you need to extract 20 times the amount of biomass to get the same amount of CBG out.”
Read more at forbes.com